Back to search

France· FR:66370559

NAROPEINE 2 mg/ml, solution injectable en poche

A ropivacaine product containing chlorhydrate de ropivacaïne monohydraté, registered in France by ASPEN PHARMA TRADING (IRLANDE). The same ATC class is registered in 17 of our 19 countries.

ATC N01BB09

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNAROPEINE 2 mg/ml, solution injectabl…ATCN01BB09REGISTER NO.FR:66370559PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Ropivacaine is registered in 17 of 19 countries.

Countries holding a registration under ATC N01BB09 (ropivacaine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Ropivacaine · ATC N01BB09

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE ROPIVACAÏNE MONOHYDRATÉ
Manufacturer
ASPEN PHARMA TRADING (IRLANDE)
Country
France (FR)
ATC code
N01BB09
ATC class
Ropivacaine
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400955994381
    5 poche(s) polypropylène de 100 ml, sous barquette stérile
  • cip13
    3400956000937
    5 poche(s) polypropylène de 200 ml, sous barquette stérile

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for ropivacaine.

Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ropivacaine · interactions on record

106 records

  • 46 moderate
  • 46 minor
  • 14 info

Most severe, free to view

  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • Obeticholic acidA05AA04moderate
  • FostamatinibB02BX09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ropivacaine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ropivacaine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ropivacain Diamed, Ropivacain Diamed Gmbh
  • Belgium · Ropivacain Hcl Noridem, Ropivacain Readyfusor Bioq Pharma
  • Bulgaria · Ропивакаин Hcl Б. Браун
  • Cyprus · Robicaine, Ropivacaine Kabi
  • Czechia · Ropivacaine Bioq
  • Germany · Naropin, Naropin Bag
  • Denmark · Ropivacain B. Braun, Ropivacain Fresenius Kabi
  • Estonia · Ropivacaine B. Braun, Ropivacaine Kabi
  • Spain · Ropivacaína Altan, Ropivacaína Altan Pharmaceuticals S.A.
  • Finland · Ropivacain Fresenius Kabi, Ropivacaine Bioq
  • United Kingdom (Northern Ireland) · Ropivacaine Altan, Ropivacaine Altan Pharmaceuticals S.A.
  • Greece · Ropivacain Hcl B. Braun, Ropivacaine /Kabi
  • Hungary · Naropin, Ropivacaine Fresenius Kabi
  • Ireland · Naropin, Ropivacaine
  • Italy · Ropivacaina Readyfusor Bioq, Ropivacaina B. Braun
  • Lithuania · Ropivacaine B. Braun, Ropivacaine Hydrochloride Kabi
  • Luxembourg · Ropivacain-Hcl B. Braun, Ropivacaine Fresenius Kabi
  • Latvia · Ropivacaine B. Braun, Ropivacaine Kabi
  • Malta · Ropivacaine Kabi
  • Netherlands · Naropin, Ropivacaïne Hcl B. Braun
  • Norway · Ropivacain Fresenius Kabi, Ropivacaine Hikma
  • Poland · Ropimol, Ropivacaine Bioq
  • Portugal · Ropegen, Ropivacaína Altan
  • Romania · Ropivacaină Infomed, Ropivacaina Kabi
  • Sweden · Ropivacain Fresenius Kabi, Ropivacaine B. Braun
  • Slovenia · Ropivakain Readyfusor Bioq Pharma, Ropivakainijev Klorid Kabi
  • Slovakia · Ropivacaine Readyfusor Bioq Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aec9fb35-714d-4af7-8956-4da5b239dc8b
GET /v1/drugs/aec9fb35-714d-4af7-8956-4da5b239dc8b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66370559",
  "date_amm": "1996-08-20",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE ROPIVACAÏNE MONOHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "infiltration;péridurale;périneurale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ropivacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.